Armstrong A, Lebwohl M, Stein Gold L, Jacobson A. Brodalumab Provides Rapid Onset of Therapeutic Response for Patients With Moderate-to-Severe Psoriasis. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s133. Available from: https://jofskin.org/33014/index.php/skin/article/view/1986